Redwood Investments, LLC Moderna, Inc. Transaction History

Redwood Investments, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 24, 2023	SELL	$118.5 - $160.53 $1.89 Million - $2.56 Million	-15,927 Reduced 77.21%	4,700 $571,000
Q1 2023 Apr 24, 2023	BUY	$135.66 - $197.02 $81,260 - $118,014	599 Added 2.99%	20,627 $3.17 Million
Q4 2022 Jan 20, 2023	BUY	$118.38 - $210.04 $1.37 Million - $2.42 Million	11,538 Added 135.9%	20,028 $0
Q3 2022 Oct 28, 2022	SELL	$118.07 - $194.18 $95,400 - $156,897	-808 Reduced 8.69%	8,490 $1 Million
Q2 2022 Jul 15, 2022	BUY	$117.13 - $176.59 $332,649 - $501,515	2,840 Added 43.98%	9,298 $1.33 Million
Q1 2022 Apr 20, 2022	SELL	$126.46 - $235.05 $1.19 Million - $2.22 Million	-9,446 Reduced 59.39%	6,458 $1.11 Million
Q4 2021 Feb 03, 2022	BUY	$225.82 - $368.51 $150,396 - $245,427	666 Added 4.37%	15,904 $4.04 Million
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $244,090 - $532,917	-1,100 Reduced 6.73%	15,238 $5.86 Million
Q2 2021 Aug 02, 2021	BUY	$129.91 - $234.98 $1.47 Million - $2.66 Million	11,338 Added 226.76%	16,338 $3.84 Million
Q1 2021 May 17, 2021	BUY	$109.18 - $185.98 $545,900 - $929,900	5,000 New	5,000 $655,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Redwood Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Redwood Investments, LLC with notifications on news.